By Adrian Manz | TraderInsight.com The global weight-loss drug market—dominated by U.S. giants Eli Lilly and Novo Nordisk—is facing a potential shake-up, and traders should take note. On Tuesday morning, Jiangsu-based Hengrui Pharma and its U.S. partner Kailera...